
eBook - ePub
Cardiovascular Endocrinology and Metabolism
Theory and Practice of Cardiometabolic Medicine
- 530 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Cardiovascular Endocrinology and Metabolism
Theory and Practice of Cardiometabolic Medicine
About this book
Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine discusses the close intersection between metabolic disorders and cardiovascular disease, covering the basic science and pathophysiology of disease and the latest research in pharmacological approaches and translational therapeutic options. This book is a valuable resource for the vascular and endocrinology clinical and research communities in need of knowledge and potential outcomes.
The global increase in the prevalence of cardiometabolic disorders, and the introduction of therapeutic options for treating metabolic disease that also lower cardiovascular risk, is bringing endocrinologists and cardiologists together in a shared clinical experience.
- Discusses the intersection between metabolic disorders and cardiovascular diseases
- Provides a comprehensive understanding of the relevant pathophysiology of diseases as a basis for the evidence-based management of cardiometabolic disorders
- Offers a comprehensive reference, ranging from basic science and pathophysiology to clinical diagnostics and management
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weāve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere ā even offline. Perfect for commutes or when youāre on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Cardiovascular Endocrinology and Metabolism by Andrew J. Krentz,Robert J. Chilton in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cardiovascular Endocrinology & Metabolism
- Chapter 1 Obesity and insulin resistance: routes to vascular disease
- Chapter 2 Diabetes mellitus and macrovascular disease: epidemiology and cardiovascular risk assessment
- Chapter 3 Complex metabolicāendocrine syndromes: associations with cardiovascular disease
- Chapter 4 Hypertension: pathophysiology and relevance to the cardiometabolic syndrome
- Chapter 5 Lipids, atherosclerosis, and microvascular disease: Translating basic science into pharmacotherapeutics
- Chapter 6 Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: pathophysiology and implications for cardiovascular disease
- Chapter 7 Cardiac energy metabolism in heart failure
- Chapter 8 Hemostatic abnormalities associated with diabetes and their clinical implications
- Chapter 9 Type 2 diabetes management: from a glucose-centric approach to cardio-renal risk reduction
- Chapter 10 Classic endocrine disorders: implications for cardiovascular disease
- Chapter 11 The fundamental role of obesity management in cardiometabolic risk reduction: nonpharmacological, pharmacological, and surgical approaches
- Chapter 12 Diabetes: evolution of multifactorial vascular risk reduction
- Chapter 13 Sodium-glucose Co-transporter-2 inhibitors: a new era of cardioprotection and renoprotection
- Chapter 14 Glucagon-like peptide-1 receptor agonists: role in the prevention and treatment of diabetes-related cardiovascular complications
- Chapter 15 Hypertension and the metabolic syndrome: toward personalized management
- Chapter 16 Proprotein convertase subtilisin kexin type 9 inhibitors and other novel lipid-modifying drugs: broadening the perspective of cardiovascular disease prevention
- Chapter 17 Heart failure: pathophysiology and the emergence of novel therapies
- Chapter 18 Interventional treatment of atherosclerotic heart disease
- Chapter 19 Peripheral arterial disease and the cardiometabolic syndrome: assessment and management
- Index